| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ANKRD12_0004700 | Intron-Exon-Intron | chr18:9182380-9235907 | chr18:9182382-9235909 | 1266 nt | 0.3894 |
| hsa_ANKRD12_0004800 | Intron-Exon-Intron | chr18:9182380-9239554 | chr18:9182382-9239556 | 250 nt | 0.2880 |
| hsa_ANKRD12_0004400 | Exon-Exon | chr18:9182380-9263886 | chr18:9182382-9263888 | 250 nt | 0.3160 |
| hsa_ANKRD12_0005600 | Exon-Exon | chr18:9195549-9204542 | chr18:9195551-9204544 | 217 nt | 0.3825 |
| hsa_ANKRD12_0005700 | Exon-Exon | chr18:9195549-9208801 | chr18:9195551-9208803 | 364 nt | 0.3929 |
| hsa_ANKRD12_0006100 | Exon-Exon | chr18:9195549-9211782 | chr18:9195551-9211784 | 565 nt | 0.3858 |
| hsa_ANKRD12_0006300 | Exon-Exon | chr18:9195549-9221997 | chr18:9195551-9221999 | 856 nt | 0.3995 |
| hsa_ANKRD12_0006500 | Intron-Exon-Intron | chr18:9195549-9235907 | chr18:9195551-9235909 | 1128 nt | 0.3892 |
| hsa_ANKRD12_0006600 | Intron-Exon-Intron | chr18:9195549-9239554 | chr18:9195551-9239556 | 250 nt | 0.2800 |
| hsa_ANKRD12_0005800 | Exon-Exon | chr18:9195549-9275665 | chr18:9195551-9275667 | 250 nt | 0.3160 |
A study in humans demonstrated that circANKRD12 circANKRD12 was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, with RT-qPCR validation showing high diagnostic efficacy as reflected by an area under the curve of 0.7819 in receiver operating characteristic analysis [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in humans demonstrated that the circANKRD12 was identified as a differentially expressed circular RNA in the peripheral blood of myocardial infarction patients and was confirmed in an AC16 cell model [Tian et al. DOI: 10.3390/molecules26041155].